Literature DB >> 10541950

The painful hip: evaluation of criteria for clinical decision-making.

G F Eich1, A Superti-Furga, F S Umbricht, U V Willi.   

Abstract

UNLABELLED: Children with a painful hip present a diagnostic challenge since clinical differentiation between septic arthritis, transient synovitis and Perthes disease may be difficult. Septic arthritis, a potentially life-threatening and debilitating medical emergency, requires early recognition for successful treatment, while transient synovitis and Perthes disease may be managed conservatively. An "ideal" single test for discrimination between these conditions is currently not available. We assessed the value of clinical examination and simple laboratory tests together with radiography and hip ultrasound in differentiating septic arthritis from transient synovitis and Perthes disease by analyzing the records of 89 children treated at our institution for hip pain. Ultrasound, radiographs, laboratory, clinical, and follow-up data were available for all the children. Diagnoses were made according to established criteria. Transient synovitis was present in 64 patients, septic arthritis in 8 (of whom 2 had additional osteomyelitis), and Perthes disease in 4. All children with septic arthritis had hip effusion shown by ultrasound and at least two of the following criteria: fever, elevation of erythrocyte sedimentation rate (ESR) and of C-reactive protein (CRP). None of the children without effusion on ultrasound or who lacked two or all criteria had septic arthritis. Radiographs had no significant impact on the decision-making in primary evaluation of acute hip pain.
CONCLUSION: We conclude that investigation of painful hips in children, based on hip ultrasound, body temperature, ESR and CRP, may allow cases for hip joint aspiration to be selected efficiently and may reduce the number of radiographs and hospital admissions.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10541950     DOI: 10.1007/s004310051243

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  9 in total

1.  Diagnostic utility of laboratory tests in septic arthritis.

Authors:  S F Li; C Cassidy; C Chang; S Gharib; J Torres
Journal:  Emerg Med J       Date:  2007-02       Impact factor: 2.740

2.  A case of bilateral suppurative arthritis of hip joint with concomitant pyomyositis.

Authors:  Halil Atmaca; Kaya Memişoğlu; Zeki Yumuk; Adem Aydın
Journal:  Balkan Med J       Date:  2012-09       Impact factor: 2.021

3.  Sonographic measurement of transient synovitis in children: diagnostic value of joint effusion.

Authors:  Koichi Yabunaka; Mutsumi Ohue; Norio Morimoto; Naoshi Kitano; Kazuyuki Shinohara; Masaki Takamura; Tatsuhiro Gotanda; Shigeru Sanada
Journal:  Radiol Phys Technol       Date:  2011-07-12

4.  Point-of-care hip ultrasound leads to expedited results in emergency department patients with suspected septic arthritis.

Authors:  Christopher Thom; Azhar Ahmed; Matthew Kongkatong; James Moak
Journal:  J Am Coll Emerg Physicians Open       Date:  2020-06-30

5.  The limping child: an algorithm to outrule musculoskeletal sepsis.

Authors:  R A Delaney; B Lenehan; L O'sullivan; A J McGuinness; J T Street
Journal:  Ir J Med Sci       Date:  2007-07-12       Impact factor: 1.568

6.  Treatment of early septic arthritis of the hip in children: comparison of results of open arthrotomy versus arthroscopic drainage.

Authors:  Ahmed Mounir Moustafa El-Sayed
Journal:  J Child Orthop       Date:  2008-03-06       Impact factor: 1.548

7.  Hip pain in the paediatric age group - transient synovitis versus septic arthritis.

Authors:  Gt Tay; M Ashik; B Tow; Kevin Bl Lim
Journal:  Malays Orthop J       Date:  2013-07

Review 8.  Paediatric bone and joint infection.

Authors:  Alexios D Iliadis; Manoj Ramachandran
Journal:  EFORT Open Rev       Date:  2017-03-13

9.  Treatment of neonatal septic arthritis sequelae of hip: a case report.

Authors:  Cen Bytyçi; Hasime Qorraj; Dafina Bytyqi
Journal:  Cases J       Date:  2009-07-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.